Prof David Hunt (@huntlabedin) 's Twitter Profile
Prof David Hunt

@huntlabedin

Professor of Neuroinflammatory Medicine at University of Edinburgh.
Wellcome Senior Clinical Fellow

ID: 1064500786724511744

calendar_today19-11-2018 12:48:59

129 Tweet

502 Followers

670 Following

Prof David Hunt (@huntlabedin) 's Twitter Profile Photo

Delighted that our work on interferon-alpha driven brain disease has made the front cover of Immunity after many years of work with brilliant collaborators in Australia, France and US. Short summary of paper to follow.

Charles Perkins Centre (@cpc_usyd) 's Twitter Profile Photo

Promising pathway discovered to treat rare childhood brain disease A study co-led by University of Sydney + Charles Perkins Centre Assoc Prof Markus Hofer + Prof Prof David Hunt reveals fresh insight into the mechanisms underlying a rare disease that can cause childhood dementia Aicardi-Goutières

Promising pathway discovered to treat rare childhood brain disease 

A study co-led by <a href="/Sydney_Uni/">University of Sydney</a>  + <a href="/CPC_usyd/">Charles Perkins Centre</a>  Assoc Prof Markus Hofer + Prof <a href="/HuntLabEdin/">Prof David Hunt</a>  reveals fresh insight into the mechanisms underlying a rare disease that can cause childhood dementia Aicardi-Goutières
Medical Research Foundation (@medresfdn) 's Twitter Profile Photo

Aicardi-Goutieres syndrome is a rare disease that can trigger #dementia in children. Previous Emerging Leaders Prize winner Prof David Hunt recently co-led a study, funded in part by Medical Research Foundation, that could lead to new treatments for this condition. bit.ly/3LQdjjM UK Dementia Research Institute

OLNI (@oxlabneuroimm) 's Twitter Profile Photo

Introducing, Oxford Laboratory for Neuroimmunology and Immunopsychiatry (OLNI)! We are a group of clinicians and scientists who want to understand how inflammation affects the brain. Annapoorna Kannan Tom Johnson Lahiru Handunnetthi Babak Soleimani Greg Holt Laurissa Watch this space!

Introducing, Oxford Laboratory for Neuroimmunology and Immunopsychiatry (OLNI)! We are a group of clinicians and scientists who want to understand how inflammation affects the brain. 

<a href="/Annapoorna2024/">Annapoorna Kannan</a> <a href="/tomj_14/">Tom Johnson</a> <a href="/handunnetthi/">Lahiru Handunnetthi</a> <a href="/babakneuro/">Babak Soleimani</a> <a href="/Greg__Holt/">Greg Holt</a> <a href="/LaurissaJoy/">Laurissa</a> 

Watch this space!
Prof David Hunt (@huntlabedin) 's Twitter Profile Photo

Work like this would struggle to go ahead without funding from the wonderful organisation that is Medical Research Foundation, who support vital research in underfunded areas.

Trends in Neurosciences (@trendsneuro) 's Twitter Profile Photo

'Unweaving type I interferons in age-related neuroinflammation' Trends in Neurosciences Spotlight by David Hunt & Markus Hofer cell.com/trends/neurosc… discussing Roy et al. 2024, Molecular Neurodegeneration, @WeiCao_PhD group …arneurodegeneration.biomedcentral.com/articles/10.11…

'Unweaving type I interferons in age-related neuroinflammation'

<a href="/TrendsNeuro/">Trends in Neurosciences</a> Spotlight by David Hunt &amp; Markus Hofer
cell.com/trends/neurosc…

discussing Roy et al. 2024, <a href="/MolNeuro/">Molecular Neurodegeneration</a>, @WeiCao_PhD group
…arneurodegeneration.biomedcentral.com/articles/10.11…
Prof David Hunt (@huntlabedin) 's Twitter Profile Photo

This meeting was a great success last year and we had lots of requests to repeat it. Save the date if you are interested in the cutting edge of neuroimmunology and MS. More information soon, please circulate

Eve smith (@evemdsmith_eve) 's Twitter Profile Photo

📣Excited to share our latest study showing: 🎯IFN-α2 levels differentiate between T2T states in cSLE 🎯Elevated IFN-α2 predictive of flare when in target ⁉️potential for biomarker-driven cSLE T2T trials 🔗 doi.org/10.1093/rheuma… Yanick Crow Prof David Hunt Valentina Natoli

Prof David Hunt (@huntlabedin) 's Twitter Profile Photo

Please RT! This was such an enjoyable event last year. Registration now open. Free registration for early careers researchers and clinicians in training who submit an abstract

Anne Rowling Regenerative Neurology Clinic (@annerowlclinic) 's Twitter Profile Photo

🗓️ Neuroimmunology & MS 2025🗓️ Registration & abstract submission is now OPEN! We have an excellent line up of topics & guest speakers covering all things neuroimmunology & MS. More info 👉 edin.ac/3NVD9UN #neuroimmunology_MS_25 #ExtraordinaryEdinburgh Pls reTweet

UK Dementia Research Institute (@ukdri) 's Twitter Profile Photo

⭐️The UK DRI exists to transform the lives of people affected by or at risk of neurodegenerative conditions.⭐️ Our vision is ‘healthy brain🧠ageing for all’. Our research will transform lives. We are the UK DRI. Medical Research Council Alzheimer's Society Alzheimer's Research UK LifeArc British Heart Foundation

Anne Rowling Regenerative Neurology Clinic (@annerowlclinic) 's Twitter Profile Photo

There’s a wide range of topics at this year’s Neuroimmunology & MS 2025 meeting. To register, submit your abstract & to view the list of topics visit: edin.ac/3NVD9UN pls share Edinburgh Neuroscience Prof David Hunt Neurosciences, RIE Peter Foley Edinburgh Imaging 💙 #neuroimmunology_MS_25

Anne Rowling Regenerative Neurology Clinic (@annerowlclinic) 's Twitter Profile Photo

🧠Calling neuroimmunology/MS clinicians, scientists, ECRs & healthcare professionals. Neuroimmunology & MS 2025 will be held in Edinburgh on 11 - 12 March 2025 & features the Belinda Weller Distinguished Lecture. Info: edin.ac/3NVD9UN Neurology Trainees Neurosciences, RIE Prof David Hunt

UK Dementia Research Institute (@ukdri) 's Twitter Profile Photo

Research by Prof David Hunt & Dr Sarah McGlasson (UK DRI at Edinburgh) sheds light on the mechanisms behind RVCL-S, a rare genetic disorder that affects small blood vessels. The study identifies an important therapeutic target👉 buff.ly/QwmdOV5

Research by <a href="/HuntLabEdin/">Prof David Hunt</a> &amp; <a href="/DrMcglasson/">Dr Sarah McGlasson</a> (UK DRI at Edinburgh) sheds light on the mechanisms behind RVCL-S, a rare genetic disorder that affects small blood vessels.

The study identifies an important therapeutic target👉 buff.ly/QwmdOV5